KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查 入排置信度 0.90

Protocol compliance in a multicentric phase III trial investigating scheduled adaptive radiotherapy and dose painting in head and neck cancer.

Anna Liza M P de Leeuw, Jordi Giralt, Yungan Tao, Sergi Benavente, Thanh-Vân F Nguyen, Frank J P Hoebers, Ann Hoeben, Chris H J Terhaard, Lip Wai Lee, Signe Friesland, Roel J H M Steenbakkers, Lisa Tans, Simon R van Kranen, Jeroen B van de Kamer, Harry Bartelink, Coen R N Rasch, Jan-Jakob Sonke, Olga Hamming-Vrieze

Radiother Oncol 202 110612

PMID39522824
PMCID-
DOI10.1016/j.radonc.2024.110612
发表日期2024-11-10
入排依据:The record describes a Phase III randomized trial in human oncology (head and neck cancer) with a time-to-event primary endpoint (locoregional control). However, the abstract focuses on quality assurance and protocol adherence analysis of the radiotherapy intervention, not on the formal efficacy results of a drug-containing intervention. No drug intervention is mentioned; the trial investigates scheduled adaptive radiotherapy and dose painting. While the primary endpoint is time-to-event, the abstract does not report Kaplan-Meier curves, hazard ratios, or other time-to-event efficacy results; it reports on the impact of protocol deviations. Therefore, it does not meet the criteria for inclusion in a KM digitization cohort requiring a drug intervention and formal time-to-event efficacy results.
摘要

摘要

PURPOSE: To report on quality assurance (QA) and protocol adherence (PA) in a multicentre phase III trial for head and neck cancer, evaluate patterns of protocol deviations and investigate the effect of PA on study outcomes. METHODS: All 221 patients from the ARTFORCE trial (NCT01504815) were included in this study. Pre- and per-treatment QA measures included protocol guidelines, a dummy run, early case reviews and trial meetings. FDG-PET-guided dose painting and scheduled adaptive radiotherapy were reviewed in patients in the experimental arm (eRT). Patient and disease characteristics, as well as institutes' accrual rate and timing were examined for correlation with PA. Cox regression was used to determine the impact of PA on outcome. RESULTS: The dummy run was completed in all nine institutes and early case reviews were completed in five out of nine institutes that contributed 190 out of 221 patients. Among all patients randomized to eRT, 64 % had at least one deviation of the experimental trial components. Protocol deviations were significantly correlated with the institute patients were treated at (Cramer'sV 0.34-0.48). Despite early identification of institute-specific deviations in QA, these continued during the trial. No significant associations were seen between deviations and accrual timing or rate (P ≥ 0.26). Within eRT, no significant relation was observed between experimental PA and locoregional control (LRC), the primary endpoint of the trial (P≥.15). CONCLUSIONS: Despite QA, protocol deviations persisted during the trial, which were mostly institute-specific. However, deviations of the experimental treatment strategy did not significantly impact LRC and therefore the trial conclusion.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。